Partnering and Business Models in Precision Medicine

Bringing a precision medicine solution to patients, comes with a unique set of challenges, especially for early-stage life sciences companies.

A key question is who is going to pay for your innovation and which business model supports the execution of such a revenue structure. Additionally, you may have to navigate complex collaborations between pharma, academia and government. Join startups, established companies, key opinion leaders as well as J&J experts in precision medicine as we discuss these unique challenges.

Early innovators, academic researchers, and entrepreneurs are welcome to register the Johnson & Johnson Innovation – JLABS program.